Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

US Patent 11083718 · Granted Aug 10, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions and uses directed to lysosomal storage disorders2025
Pharmaceutical compositions and uses directed to lysosomal storage disorders2025
Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobili2025
Therapeutic agents for neurodegenerative diseases2024
Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxid2024
Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobili2024
Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxid2023
Therapeutic agents for treating restless leg syndrome2023
Treatment for migraine2022
Pharmaceutical compositions and uses directed to lysosomal storage disorders2022
Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobili2021
Vibration isolating engine cooling fan2016